Edmond DE Rothschild Holding S.A. raised its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 107.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 687,832 shares of the medical equipment provider’s stock after buying an additional 356,510 shares during the quarter. Edmond […]
Edmond DE Rothschild Holding S.A. raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 107.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 687,832 shares of the medical equipment provider’s stock after purchasing an additional 356,510 shares during the […]
AAFMAA Wealth Management & Trust LLC acquired a new position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 20,096 shares of the medical equipment provider’s stock, valued at approximately $1,162,000. A number of other hedge […]
Advisory Services Network LLC grew its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 5.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,398 shares of the medical equipment provider’s stock after purchasing an additional 2,362 […]
The global neurostimulation devices market is experiencing substantial growth, driven by advancements in technology and an increasing prevalence of neurological disorders. The market size is projected to expand from USD 11.1 billion in 2022 to USD 36.5 billion by 2032, growing at a compound annual growth rate (CAGR).